| Literature DB >> 23427199 |
Lisa J Mackenzie1, Rob W Sanson-Fisher, Mariko L Carey, Catherine A D'Este.
Abstract
OBJECTIVES: We aimed to describe the proportion and characteristics of cancer patients who perceived that better care would have greatly improved their well-being in (1) specific and (2) multiple domains of patient-centred care.Entities:
Year: 2013 PMID: 23427199 PMCID: PMC3586157 DOI: 10.1136/bmjopen-2012-001265
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Survey items and descriptions (each assessing a different domain of care)
| Item | On screen description |
|---|---|
| Better management of my physical symptoms | May relate to your pain, sleeplessness, other side-effects and symptoms |
| Better information and communication about my cancer and care | May include: clear and consistent information about your diagnosis, test results, treatment, taking medications, food you should be eating, exercise you can do safely, etc |
| Better emotional and/or spiritual support | May include services or support to help you cope with: the impact of cancer on your life, doubts/worries, feelings of anxiety or sadness, changes to your body images, etc |
| Better services, information and support for my friends/family | May include helping them to cope with the impact of your cancer, or providing opportunities for them to be involved in your care |
| Better staff approachability and respect for me | Describes staff who are easy to contact and up-to-date with your medical history, and who give you opportunities to ask questions and be involved in treatment decisions |
| Getting better access to the care I need when required | Describes not having to wait too long to get appointments, and having treatment and medical advice available when needed |
| Better services/support to cope with changes to my relationships | May include: knowing what changes to expect, and having some strategies to reduce the impact of cancer on your work, usual social activities, friendships or sexual relationships |
| Better services/advice to assist me with practical concerns | May include being able to access financial support, transport to treatment, home help services or other support needed to manage practical issues |
Demographic and disease characteristics of respondents (n=344)
| Characteristic | Mean (min, max) |
|---|---|
| Age (years) | 61.4 (18.9–91.4) |
| Males | 176 (51%) |
| Region of birth | |
| Australia | 231 (67%) |
| UK/Ireland | 30 (8.7%) |
| Europe | 29 (8.4%) |
| Asia | 25 (7.2%) |
| Other | 29 (8.4%) |
| Perceived palliative treatment aim | 46 (14%) |
| Primary cancer type | |
| Breast | 93 (27%) |
| Prostate | 73 (21%) |
| Head and neck | 33 (9.6%) |
| Colorectal | 20 (5.8%) |
| Brain | 15 (4.4%) |
| Lung | 15 (4.4%) |
| Other | 89 (26%) |
| Don't know | 6 (1.7%) |
| Second diagnosis/recurrence | 96 (28%) |
| Completed appointments with cancer doctor | 3 (2, 5) |
| Completed radiation therapy appointments | 9 (4, 17) |
| Weeks since diagnosis | 27.6 (16, 37.3) |
Note: Observations within each variable may not add to the total due to missing values.
Proportion who reported that their well-being would have been improved by better care across eight domains (n=344)
| Agree | |
|---|---|
| n (%, 95% CI) | |
| Information and communication about my cancer and care | 76 (22, 18–27) |
| Emotional and/or spiritual support | 75 (22, 18–27) |
| Management of my physical symptoms | 72 (21, 17–26) |
| Services; information and support for my friends/family | 72 (21, 17–26) |
| Services/advice to assist me with practical concerns | 69 (20, 16–25) |
| Access to the care I need when required | 62 (18, 14–23) |
| Services/support to cope with changes to my relationships | 56 (16, 13–21) |
| Staff approachability and respect for me | 42 (12, 8.9–16) |
Figure 1Percentage of respondents endorsing 0–8 domains in which better care would have greatly improved their well-being.
Demographic, disease and HADS associations with endorsement of multiple domains as requiring improvement†
| Multiple domains endorsed n (%) | LR χ2, p value | LR χ2, p value | |
|---|---|---|---|
| Unadjusted OR (95% CI)‡ | Adjusted OR (95% CI)‡ | ||
| Hospital | 5.0, p=0.1752 | 2.9, p=0.4002 | |
| Site 1 | 36 (36%) | 1.0 | 1.0 |
| Site 2 | 22 (23%) | 0.5 (0.3 to 1.0) | 0.6 (0.3 to 1.2) |
| Site 3 | 23 (32%) | 0.8 (0.4 to 1.6) | 0.9 (0.4 to 1.8) |
| Site 4 | 26 (34%) | 0.9 (0.5 to 1.7) | 1.0 (0.5 to 2.0) |
| Age category | 35.9, p<0.0001 | 28.9, p<0.0001**** | |
| 18–49 years | 36 (51%) | 1.0 | 1.0 |
| 50–59 years | 34 (46%) | 0.8 (0.4 to 1.5) | 0.7 (0.4 to 1.4) |
| 60–69 years | 20 (18%) | 0.2 (0.1 to 0.4) | 0.2 (0.1 to 0.4) |
| 70 years plus | 17 (19%) | 0.2 (0.1 to 0.4) | 0.2 (0.1 to 0.5) |
| Sex§ | 2.5, p=0.1159 | ||
| Male | 48 (27%) | 1.0 | |
| Female | 59 (35%) | 1.4 (0.9 to 2.3) | |
| Cancer type§ | 3.8, p=0.1469 | ||
| Breast | 31 (33%) | 1.0 | |
| Prostate | 16 (22%) | 0.6 (0.3 to 1.1) | |
| Other cancer types¶ | 60 (34%) | 1.0 (0.6 to 1.7) | |
| Second diagnosis or recurrence | 1.0, p=0.3123 | ||
| No | 81 (33%) | 1.0 | |
| Yes | 26 (27%) | 0.8 (0.5 to 1.3) | |
| Born in Australia | 8.5, p=0.0037 | 5.4, p=0.0205* | |
| No | 47 (42%) | 1.0 | 1.0 |
| Yes | 60 (26%) | 0.5 (0.3 to 0.8) | 0.5 (0.3 to 0.9) |
| Socioeconomic status | 0.3, p=0.5758 | ||
| Low | 5 (22%) | 1.0 | |
| Medium | 8 (16%) | 0.7 (0.2 to 2.4) | |
| High | 59 (22%) | 1.0 (0.4 to 2.9) | |
| Usual place of residence | 0.3, p=0.5758 | ||
| Major city | 87 (32%) | 1.0 | |
| Regional or rural | 19 (28%) | 0.8 (0.5 to 1.5) | |
| Living with partner | 5.2, p=0.0224 | 3.9, p=0.0481* | |
| No | 50 (38%) | 1.0 | 1.0 |
| Yes | 57 (27%) | 0.6 (0.4 to 0.9) | 0.6 (0.4 to 1.0) |
| Clinically significant anxiety†† | 10.4, p=0.0013 | 4.3, p=0.0383* | |
| No | 82 (28%) | 1.0 | 1.0 |
| Yes | 25 (52%) | 2.8 (1.5 to 5.2) | 2.1 (1.0 to 4.1) |
| Clinically significant depression§†† | 5.7, p=0.0167 | ||
| No | 97 (30%) | 1 | |
| Yes | 10 (59%) | 3.3 (1.2 to 9.0) | |
| Completed radiation therapy appointments | 0.02, p=0.8893 |
Note: Observations within each variable may not add to the total due to missing values.
*p<0.05 **p<0.01 ***p<0.001 ****p<0.0001
†p-values for the Hosmer-Lemeshow goodness of fit test were between 0.2 and 0.9 for specific domain models; and was 0.1 for the multiple domain model (Table 4 description, line 755).
‡Reported p-values are from the Likelihood ratio test (Table 4, Column 3 and 4 headers).
§Eliminated during backwards stepwise multiple logistic regression analysis.
¶Including brain, colorectal, head and neck, lung, non-Hodgkin's lymphoma, and other cancer types.
††Assessed using the Hospital Anxiety and Depression Scale (HADS).